Ascendis Pharma A/S (NASDAQ:ASND) Upgraded to “Strong-Buy” by Evercore ISI
Evercore ISI upgraded shares of Ascendis Pharma A/S (NASDAQ:ASND – Free Report) to a strong-buy rating in a report published on Monday, Zacks.com reports. Other equities analysts have also recently issued research reports about the company. JPMorgan Chase & Co. lifted their target price on Ascendis Pharma A/S from $170.00 to $174.00 and gave the […]
More Stories
Future plc (LON:FUTR) Announces Dividend of GBX 3.40
Future plc (LON:FUTR – Get Free Report) announced a dividend on Friday, December 5th,Upcoming Dividends.Co.Uk reports. Investors of record on...
XAI Octagon Floating Rate & Alternative Income Trust (XFLT) to Issue Monthly Dividend of $0.08 on February 3rd
XAI Octagon Floating Rate & Alternative Income Trust (NYSE:XFLT – Get Free Report) announced a monthly dividend on Thursday, January...
AbbVie Inc. (NYSE:ABBV) Shares Acquired by Eastern Bank
Eastern Bank grew its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 36.7% in the 4th quarter, according to...
Miracle Mile Advisors LLC Increases Stock Holdings in Alphabet Inc. (NASDAQ:GOOG)
Miracle Mile Advisors LLC grew its holdings in Alphabet Inc. (NASDAQ:GOOG – Free Report) by 48.1% in the 4th quarter,...
Eastern Bank Purchases 6,070 Shares of Visa Inc. (NYSE:V)
Eastern Bank boosted its stake in shares of Visa Inc. (NYSE:V – Free Report) by 1.9% during the fourth quarter,...
Asia Dragon (DGN) To Go Ex-Dividend on January 16th
Asia Dragon (LON:DGN – Get Free Report) announced a dividend on Thursday, January 9th,Upcoming Dividends.Co.Uk reports. Stockholders of record on...